Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2025
Rhea-AI Summary
Positive
- Regular dividend payment indicates financial stability and commitment to shareholder returns
- Consistent dividend policy maintained at $0.24 per share
Negative
- None.
News Market Reaction – ZBH
In the trading session that priced this news, ZBH declined 1.25%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.
With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.
For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.
Media | Investors |
Heather Zoumas-Lubeski | David DeMartino |
445-248-0577 | 646-531-6115 |
Zach Weiner | |
908-591-6955 | |
View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-announces-quarterly-dividend-for-second-quarter-of-2025-302468938.html
SOURCE Zimmer Biomet Holdings, Inc.